Technical Analysis for MBX - MBX Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 16.14 | 1.25% | 0.20 |
MBX closed down 2.92 percent on Tuesday, November 19, 2024, on 1.11 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 1.25% | |
| Doji - Bullish? | Reversal | 1.25% | |
| Lower Bollinger Band Walk | Weakness | 1.25% | |
| New 52 Week Low | Weakness | 1.25% | |
| Wide Bands | Range Expansion | 1.25% | |
| Below Lower BB | Weakness | 1.25% | |
| Down 3 Days in a Row | Weakness | 1.25% | |
| Down 4 Days in a Row | Weakness | 1.25% | |
| Down 5 Days in a Row | Weakness | 1.25% | |
| Gapped Down | Weakness | 1.25% |
| Alert | Time |
|---|---|
| Down 3% | about 1 hour ago |
| Up 3% | about 1 hour ago |
| Fell Below Previous Day's Low | about 1 hour ago |
| Down 2 % | about 1 hour ago |
| Down 1% | about 1 hour ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Obesity Metabolic Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Obesity Metabolic Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.19 |
| 52 Week Low | 15.57 |
| Average Volume | 114,540 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 21.36 |
| 10-Day Moving Average | 20.54 |
| Average True Range | 2.32 |
| RSI (14) | 27.54 |
| ADX | 21.99 |
| +DI | 9.80 |
| -DI | 27.60 |
| Chandelier Exit (Long, 3 ATRs) | 18.85 |
| Chandelier Exit (Short, 3 ATRs) | 22.52 |
| Upper Bollinger Bands | 25.88 |
| Lower Bollinger Band | 16.84 |
| Percent B (%b) | -0.1 |
| BandWidth | 42.33 |
| MACD Line | -1.36 |
| MACD Signal Line | -0.63 |
| MACD Histogram | -0.7373 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 19.26 | ||||
| Resistance 3 (R3) | 19.50 | 18.64 | 18.70 | ||
| Resistance 2 (R2) | 18.64 | 17.80 | 18.52 | 18.52 | |
| Resistance 1 (R1) | 17.29 | 17.27 | 17.97 | 17.05 | 18.33 |
| Pivot Point | 16.43 | 16.43 | 16.77 | 16.31 | 16.43 |
| Support 1 (S1) | 15.08 | 15.59 | 15.76 | 14.84 | 13.55 |
| Support 2 (S2) | 14.22 | 15.06 | 14.10 | 13.36 | |
| Support 3 (S3) | 12.87 | 14.22 | 13.18 | ||
| Support 4 (S4) | 12.63 |
